Cinven is reviewing strategic options for laboratory-services company Synlab International GmbH including a potential sale, people with knowledge of the matter said.
The private equity firm has been speaking with potential advisers and could start a sale process early next year, the people said, asking not to be identified because the information is private. Cinven plans to seek a valuation of about 5.5 billion euros ($6 billion) including debt for Augsburg, Germany-based Synlab, one of the people said.
A sale of Synlab would likely attract other private equity firms, the people said. No final decision has been made, and Cinven could elect to keep the business, the people said. A spokeswoman for Cinven declined to comment, while Synlab didn’t answer phone calls seeking comment.
Cinven first invested in Synlab in June 2015, buying a majority stake from fellow private equity firm BC Partners for about 1.7 billion euros, Bloomberg News reported at the time. It combined the business with Labco SA, which it agreed to buy earlier that year for 1.2 billion euros.
Synlab, led by Chief Executive Officer Mathieu Floreani, also counts Novo A/S and Ontario Teachers’ Pension Plan as minority investors, according to its website. It operates across more than 40 countries, handling more than 500 million clinical tests annually, according to Synlab’s website.
Cinven also owns stakes in retailer Kurt Geiger and German drugmaker Stada Arzneimittel AG, according to its website.
The sale plan comes at a time when Cinven’s rival Apax Partners is also weighing a sale of diagnostic services business Unilabs. The buyout firm is working with advisers at Rothschild & Co. to look at options for the business, people familiar with the matter said last week.
Source: Bloomberg
Can’t stop reading? Read more
Partners Group hits $9bn close for flagship secondaries programme
Partners Group hits $9bn close for flagship secondaries programme Partners Group has closed its latest private equity secondaries programme with more than $9bn in commitments. The programme, which includes a flagship closed-end fund alongside bespoke mandates and...
Sequoia raises $7bn expansion fund to double down on AI and late-stage bets
Sequoia raises $7bn expansion fund to double down on AI and late-stage bets Sequoia Capital has raised approximately $7bn for a new expansion fund, as the venture capital firm scales its late-stage investment strategy under new leadership, according to sources...
General Atlantic brings in Abu Dhabi capital at $1.8bn valuation for Joe & the Juice
General Atlantic brings in Abu Dhabi capital at $1.8bn valuation for Joe & the Juice General Atlantic has secured a new minority investment in Joe & the Juice from Emirates International Investment Co., in a transaction valuing the global food and beverage...